FlaggedRx← Medication recall checkHome
Class II · ModerateRecall completed

CLONAZEPAM ORALLY DISINTERGRATING Tablets

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberLot # 32900136A, Exp. 05/14
Where it was soldNC
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Distributed by / forTeva Pharmaceuticals USA, Inc.
NDC0555-0096-96
Show the full FDA record
Full product labelCLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA PHARMACEUTICALS USA, Sellersville PA 18960, NDC #0555-0096-96
Recalling firmTeva Pharmaceuticals USA, Inc.
DistributionNC
Quantity3 boxes
Recall initiated2013-02-07
Report date2013-04-10
Recall completed2014-01-15
Recall numberD-237-2013
ClassificationClass II
FDA statusTerminated
Origin on fileSellersville PA United States

Related

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.